Renal changes induced by nitric oxide and prostaglandin synthesis reduction: Effects of trandolapril and verapamil

Hypertension

Volumn 31, Issue 2, 1998, Pages 657-664

  Llinás, Maria T ^b   González, Juan D ^b   Rodríguez, Francisca ^b   Nava, Eduardo ^b   Taddei, Stefano ^a   Salazar, F Javier ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Calcium antagonists converting enzyme inhibitors; Nitric oxide; Prostaglandin; Sodium sensitivity; Vasoconstriction

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MECLOFENAMIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; TRANDOLAPRIL; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG MIXTURE; GLOMERULUS FILTRATION RATE; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; SODIUM EXCRETION;

EID: 0344110395     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.2.657     Document Type: Article

References (29)

1. Alberola A, Pinilla JM, Quesada T, Romero JC, Salazar FJ. Role of nitric oxide in mediating renal response to volume expansion. Hypertension. 1992; 19:780-784.
2. Salazar FJ, Llinás MT, González JD, Quesada T, Pinilla JM. Role of prostaglandins and nitric oxide in mediating renal response to volume expansion. Am J Physiol. 1995;268:R1442-R1448.
3. Llinás MT, González JD, Nava E, Salazar FJ. Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition. J Am Soc Nephrol. 1997;8:543-550.
4. Salazar FJ, Alberola A, Romero JC, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993; 22:49-55.
5. Yamada SS, Sassaki AL, Fujihara CK, Malheiros DM, De Nucci G, Zatz R. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension. 1996;27: 1165-1172.
6. Lüscher TF, Dohi Y, Tschdi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol. 1992;19(suppl 5):S34-S42.
7. Ferri C, Bellini C, Piccoli A, Carlomagno A, Bonavita MS, Santucci A, Balsano F. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertension. 1993;21: 875-881.
8. Llinás MT, González JD, Salazar FJ. Effects of verapamil on the renal actions induced by nitric oxide and prostaglandins synthesis inhibition. Am J Hyperten. 1996;9:973-981.
9. Osswald H, Mühlbauer B. The pharmacological basis for the combination of calcium channel antagonists and angiotensin enzyme inhibitors in the treatment of hypertension. J Hypertens. 1995;13(suppl 2):21-28.
10. Menard J, Bellet M. Calcium amagonists-ACE inhibitors combination therapy: objectives and methodology of clinical development. J Cadiovasc Pharmacol. 1993;21(suppl 2):S49-S54.
11. Morgan TO, Anderson A. Hemodynamic comparisons of enalapril and felodipine and their combination. Kidney Int. 1992;41(suppl 36):S78-S81.
12. Houston MC. Nonsteroidal anti-inflammatory drugs and anti-hypertensives. Am J Med. 1991;90(suppl 5A):S42-S47.
13. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Hypertension. 1991;18:67-71.
14. Weinberger MH. Stegner JE, Fineberg NS. A comparison of two tests for the assessment of blood pressure responses to sodium. Am J Hypertens. 1993;6:179-184.
15. Waeber B, Brunner H. Main objectives and new aspects of combination treatment of hypertension. J Hypertens. 1995;13(suppl 2):S15-S19.
16. Baylis C, Engels K, Samsell L, Harton P. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II. Am J Physiol. 1993;264:F74-F78.
17. Granger JP, Alberola AM, Salazar FJ, Nakamura T. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J Cardiovasc Pharmacol. 1992;20(suppl 12):S160-S162.
18. Stoos BA, Carretero OA, Garvin JL. Endothelium-derived relaxing factor inhibits transport and increase cGMP content in cultured mouse cortical collecting ducts. J Clin Invest. 1992;89:761-765.
19. 2 on chloride transport across the rabbit thick ascending limb of Henle: selective inhibition of the medullary portion. J Clin Invest. 1979;64:495-502.
20. Martson DL, Roman RJ, Cowley AW. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension. 1992;19:766-769.
21. Nakamura T, Alberola AM, Granger JP. Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide. Hypertension. 1993;21:956-960.
22. Granger JP. Pressure natriuresis: role of renal interstitial hydrostatic pressure. Hypertension. 1992;19(suppl I):I-9-I-17.
23. Romero JC, Knox FG. Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandins systems. Hypertension. 1988;11:724-738.
24. Carmines PK, Mitchell KD, Navar LG. Effects of calcium antagonists on renal hemodynamics and glomerular function. Kidney Int. 1992;41(suppl 36):43-48.
25. Romero JC, Raij L, Granger JP, Ruilope LM, Rodicio JL. Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension. 1987;10:140-151.
26. Larochelle P. Renal tubular effects of calcium antagonists. Kidney Int. 1992;41(suppl 36):S49-S53.
27. Tobian L. Salt and hypertension. In: Genest J, Koiw E, Kuchel O, eds. Hypertension: Physiopathology and Treatment. New York, NY: McGraw-Hill; 1977:423-433.
28. Levine JH, Ferdinand KC, Cargo P, Laine H, Lefkowitz M. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. Am J Hypertens. 1995;8:494-499.
29. Bainbridge AD, MacFadyen RJ, Lees KR, Reid JL. A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects. Br J Clin Phamacol. 1991;31:148-153.